What is the aim of immunosuppressive treatment in patients with graves' orbitopathy?

@article{Yang2014WhatIT,
  title={What is the aim of immunosuppressive treatment in patients with graves' orbitopathy?},
  author={Morgan Yang and Wilmar Maarten Wiersinga and Maarten R. Soeters and Maarten Ph. Mourits},
  journal={Ophthalmic plastic and reconstructive surgery},
  year={2014},
  volume={30 2},
  pages={157-61}
}
PURPOSE The EUGOGO criteria and the clinical activity score (CAS) have been used as outcome measures to report response rates for patients after pulsed intravenous methylprednisolone (PIM) therapy. This study compares the results after PIM for both criteria and evaluates the number of rehabilitative surgeries performed in relation to treatment outcome. METHODS This was a retrospective review of patients with active moderate-to-severe Graves' orbitopathy (GO) treated with PIM (cumulative dose… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS